Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing May 27, 2020checkorphan Learn more about: Acute erythroblastic leukemia Related Clinical Trial Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing Recruitment InformationAdministrative Informations
